The U.S. Food and Drug Administration has extended its review for the expanded use of Travere Therapeutics’ drug to treat a ...

In 2025, the FDA approved six drugs to treat various kidney diseases, including updates for Ozempic and the first approval of ...

Chronic kidney disease can quietly reshape a life long before the first lab test comes back abnormal. More than 700 million ...

Kidney diseases, particularly chronic kidney disease (CKD), fundamentally impair the kidneys' ability to eliminate waste ...

One 26-year-old mother of six in Arkansas is reaching out for the public’s help as she battles stage 5 kidney failure and ...

Chronic kidney disease (CKD) is a progressive condition that leads to the gradual loss of renal function, often resulting in a myriad of metabolic and electrolyte disturbances. Among these, disorders ...

The incidence of kidney disease is substantially higher in patients with Down syndrome than in control individuals from the ...

Diabetic kidney disease affects a growing proportion of people with diabetes and remains the leading cause of end-stage renal disease.

The number of people living with CKD worldwide rose from 378 million in 1990 to 788 million in 2023. Here is what is ...

The increased kidney failure risk among patients with monogenic kidney disorders supports genetic testing in routine clinical practice and research on potential new therapies. Patients with monogenic ...

Chronic kidney disease (CKD) severity is associated with an increased risk for gastroparesis, according to a study published ...